Verified
“Uses patented Siliphos silybin-phospholipid phytosome”
The label specifies the patented Siliphos raw material standardized to 29–36% silybin — the same silybin-phosphatidylcholine complex used in premium phytosomes.
Reviewed
Verified by SAC team
+20
XP on completion
Best Budget Phytosome
Swanson
Swanson Siliphos Milk Thistle Phytosome (Standardized) 300 mg, 60 Capsules Review
7.1/10SAC Product Score™
If the phytosome form matters to you but the premium price tags don't, this is the honest budget route to the absorption tech that makes milk thistle worth taking. Swanson uses the same patented Siliphos silybin-phospholipid raw material as premium brands, standardized to the bioactive silybin isomer. Be clear-eyed about the compromises: it's the only pick here with no third-party testing claim, the capsule is gelatin, and the silybin per cap is modest.
Check on AmazonAffiliate link — Super Achiever Club earns a small commission at no extra cost to you.
Read the complete Milk Thistle (Silymarin) guide →How we built the SAC Product Score™ — 7.1/10
Form & Bioavailability30%9/10
A genuine Siliphos silybin-phytosome — the same patented silybin-phosphatidylcholine tech premium phytosomes use. On the highest-weighted axis it grades near the top, because this is the delivery form milk thistle actually needs.
Silymarin/Silybin Dose vs Clinical Range25%6.8/10
~90–108 mg silybin per capsule (29–36% of 300 mg Siliphos). Standardized to the bioactive isomer, but the per-cap load is modest, so reaching a full dose means 2–3 capsules a day.
Third-Party Testing & Quality Assurance20%5/10
The weak point: this is the only pick with no third-party testing claim — in-house GMP only. On the 20%-weighted QC axis that's the single biggest reason it sits outside the top tier.
Value per Effective Serving15%7.5/10
The lowest-cost phytosome in the set at ~$16. Even accounting for 2–3 caps/day to reach a full dose, it's the cheapest way to buy the absorption tech — strong value for the form.
Formulation Suitability & Tolerability10%6/10
Gelatin capsules, so not vegan, and no allergen certifications highlighted. Generally tolerable, but the format limits suitability for plant-based users.
The product at a glance
- Form
- Siliphos silybin phytosome (silybin-phosphatidylcholine), gelatin cap
- Silybin load
- ~90–108 mg silybin per capsule (29–36% of 300 mg Siliphos)
- Supply
- 60 capsules (label: 1 cap 1–3× daily)
- Standardization
- 29–36% silybin (patented Siliphos raw material)
- Testing
- In-house GMP facility only
- Price
- ~$16
- Cost per serving
- ~$0.27/cap (~$0.53–0.80/day at 2–3 caps)
Marketing claims vs. reality
Verified
“Phytosome improves absorption over plain extract”
Silybin-phospholipid complexes are shown in pharmacokinetic studies to raise plasma silybin versus unformulated extract.
Not verified
“Third-party tested”
No third-party testing claim is made; the product states in-house GMP manufacturing only, so testing is not independently attested.
Partial
“Supports liver health”
Better-absorbed silybin is a reasonable mechanism, but clinical outcomes remain mixed (Rambaldi 2007), so a liver-protection claim is only partially supported.
What our test actually found
01Same tech, lower price
Siliphos is the identical patented silybin-phospholipid raw material found in premium phytosomes. Getting it for ~$16 is the whole reason this pick exists — form-for-the-money, it's the best value on the page.
02Modest silybin per cap
At ~90–108 mg silybin each, one capsule is a partial dose; the label's 1–3 caps/day range reflects that. Budget for 2–3 daily, which still keeps the per-day cost low.
03The QC gap is the story
It's the only pick here with no third-party testing claim — in-house GMP only. On a 20%-weighted axis that single gap is exactly what keeps a top-tier form out of the top tier.
04Gelatin, not vegan
The capsule is gelatin, ruling it out for plant-based buyers. Combined with the thin QC paper trail, that's the trade you accept for the low price.
Pros & cons, no sugar-coating
Pros
- Budget entry into phytosome (Siliphos) bioavailability — milk thistle's key absorption lever
- Standardized to the bioactive silybin isomer (~90–108 mg/cap)
- Lowest-cost phytosome option in the set
- Patented Siliphos raw material, same tech as premium brands
Cons
- The only pick with no third-party testing claim — in-house GMP only
- Gelatin capsules, so not vegan
- Modest silybin per cap means 2–3 caps/day for a full dose
Best form-for-the-money, weakest paper trail
If the phytosome form matters to you but the premium price tags don't, this is the honest budget route to the absorption tech that makes milk thistle worth taking. Be clear-eyed about the compromises: it's the only option here with no third-party testing claim, the capsule is gelatin, and the silybin per cap is modest. Best form-for-the-money on the page — just the weakest QC paper trail, which is exactly what keeps it out of the top tier.
Check Swanson on AmazonIf this doesn’t fit — try these
Thorne Milk Thistle Phytosome
8.6/10The premium version of the same idea — soy-free, top-tier third-party QC.
See it on the list →Life Extension Advanced Milk Thistle
8.4/10A Siliphos fraction plus a much higher standardized dose, with NSF-registered manufacturing.
See it on the list →Nutricost Milk Thistle 300 mg
7.5/10If you'd rather have documented testing and a higher dose than a budget phytosome.
See it on the list →Sources & further reading
- Rambaldi A, Jacobs BP, Gluud C. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database Syst Rev. 2007;(4):CD003620.Rambaldi A, Jacobs BP, Gluud C · 2007 · Cochrane Database of Systematic Reviews · PMID 17943794
Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases
Found no significant effect on mortality even where absorption is improved.
- Gillessen A, Schmidt HH. Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review. Adv Ther. 2020;37(4):1279-1301.Gillessen A, Schmidt HH · 2020 · Advances in Therapy · PMID 32065376
Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review
Reports supportive effects of silymarin, noting bioavailability as a key limitation addressed by phytosome forms.